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Is stopping of anticoagulant therapy really required 
in a minor dental surgery? 
- How about in an endodontic microsurgery? 
Nowadays, oral anticoagulants are commonly prescribed to numerous patients for 
preventing cardiovascular accident such as thromboembolism. An important side 
effect of anticoagulant is anti-hemostasis. In a major surgery, the oral anticoagulant 
therapy (OAT) regimen must be changed before the surgery for proper post-operative 
bleeding control. However, in a minor dental surgery and endodontic surgery, the 
necessity for changing or discontinuing the OAT is open to debate. In this study, risks 
of the consequences were weighed and analyzed. In patients who stop the OAT, the 
occurrence of thromboembolic complication is rare but the result is fatal. In patients 
who continuing the OAT, post-operative bleeding can be controlled well with the local 
hemostatic measures. In the endodontic surgery, there are almost no studies about this 
issue. The intra-operative bleeding control is particularly important in the endodontic 
surgery because of its delicate and sensitive procedures such as inspection of resected 
root surface using dental microscope and retrograde filling. Further studies are 
necessary about this issue in the viewpoint of endodontic surgery. (Restor Dent Endod 
2013;38(3):113-118)
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Introduction
The oral anticoagulant is commonly prescribed for preventing complications such 
as thromboembolism in patients with prosthetic heart valves, congestive heart 
failures and valvular defects.1,2 One side effect of this beneficial drug is that it makes 
prolonged bleeding time after surgical procedures because its anticoagulative action is 
antagonistic to vitamin K which is essential to achieve hemostasis.1-3
In order to monitor the anticoagulation level, the use of the international normalized 
ratio (INR) has been recommended.4-8 The recommended therapeutic range of INR 
is 2 to 3 for general indications, but more strict level of anticoagulation is required 
for patients with prosthetic valves: INR range 3 to 4.1,5,7,8 In the medical field, if the 
INR range is between 2 to 4, a major general surgery is not performed because it has 
potential to induce much hemorrhage which cannot be controlled without changing or 
discontinuing the oral anticoagulant therapy (OAT).1,2,7 If a major surgery is proceeded 
without any consideration of changing or stopping anticoagulants, severe post-
operative bleeding can occur and it may lead patients to life-threatening situations. 
But, in a minor dental surgery such as extraction, periodontal surgery and endodontic 
surgery, the necessity of changing or discontinuing the OAT is still questionable.
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In a normal patient, most of minor dental surgery can 
be performed under local anesthesia with vasoconstrictor, 
and post-operative hemorrhage can be controlled in 
most circumstances with local hemostatic methods 
such as local hemostatic material (bonewax, surgicel, 
etc.), local hemostatic agent(epinephrine solution, 
ferric sulfate, calcium sulfate, etc.), suture, pressure 
dressing, and periodontal pack application.5,9-16 However, 
the effectiveness of the local hemostatic methods in 
patients who take the anticoagulants is not well known. 
Especially in endodontic surgery, it is important to 
control the intra-operative hemorrhage as well as post-
operative hemorrhage. Inadequate bleeding control during 
endodontic surgery leads to the failure of apical seal, and 
it may result in the failure of endodontic surgery itself.17 
Thus, it is also important to investigate the necessity of 
changing or discontinuing the OAT in endodontic surgery.
The purpose of this paper is to review the literatures 
about evidence that supports either changing/
discontinuing or continuing the OAT for minor dental 
surgery and endodontic surgery, and to suggest the 
strategies for patients taking the OAT.
Review 
Risk assessment
1. Risk of thromboembolism - Discontinue the OAT
When the patients stop the OAT, many studies reported 
that the risk of thromboembolism increases. In Michael’s 
study, after discontinuing the OAT in 169 patients, 
the thromboembolic event occurred in 22% patients. 
Furthermore, 7 patients died due to thromboembolism.18 
In this study, the author said that if anyone stops the OAT, 
he or she will soon encounter the risk of thromboembolic 
event regardless of the period of discontinuation. 
Furthermore, there is no method to select the low-risk 
patient, so OAT should be continued for the patient’s whole 
life. Tulloch and Wright reported a case of a patient who 
discontinued the OAT for 8 days before the oral surgery, and 
re-took the OAT just after the surgery. Two days after the 
surgery, cerebral embolus occurred to that patient, and 4 
days after the surgery, branchial artery embolus occurred.19 
Akbarian et al. also reported a similar case that after 
temporary discontinuation of the OAT for dental procedures, 
the thromboembolism occurred, which later led the patient 
to death.20 In 1998, Wahl reviewed the papers about fatal 
complications after withdrawal of the OAT from 1950 to 
1997. There were 4 deaths and 2 nonfatal embolisms in 493 
patients, and incidence of thromboembolic complication 
was about 1%. This is a small number of incidences, but 
the outcomes were very serious.16
2. Risk of hemorrhage - Continue the OAT
In 1957 Ziffer et al. reported two cases that the profound 
bleeding occurred after dental extraction in the patients 
who continued the OAT during the extraction21. After this 
case report, few case reports about post-operative bleeding 
as a consequence of continuing the OAT were followed by 
other authors.22
However, Wahl reviewed more than 2,400 cases of 
dental surgical procedure performed on more than 950 
patients receiving the continuous OAT. Only 12 patients 
(13 cases) experienced post-operative bleeding which 
later was controlled by local measures.16 The author 
suspected that in three of those 12 patients, the post-
operative bleeding might have been caused by the 
concomitant administration of antibiotics. Antibiotics such 
as erythromycin and penicillin may enhance warfarin’s 
anticoagulant effect, especially when administered in 
multiple doses.23,24 Campbell et al. reported that there 
is no significant difference in total blood loss during 
surgical procedure between continued OAT group and 
withdrawn OAT group at randomized controlled trial.25 In a 
systematic review of Madrid and Sanz, the authors studied 
five randomized controlled trials and 11 controlled trials. 
They concluded that the results from these studies were 
very homogenous and showed minor bleedings in very few 
OAT-stopped patients without significant differences.26 In 
other words, there was no significant difference in post-
operative hemorrhage between the patients who continued 
the OAT with the recommended INR range of 2 to 4 and the 
patients who discontinued the OAT. Also, post-operative 
bleeding did not correlate with the INR status.
In most studies, post-operative bleeding was controlled 
well only with local hemostatic measures, such as 
tranexamic acid mouthwashes, gelatin sponges and 
cellulose gauze application.8,10-12,14,15,27 The incidence of 
postoperative bleeding which could not be controlled by 
the common local measures varied from 0% to 3.5%.13,28 It 
is also reported that when the post-operative hemorrhage 
occurred, the cause was not necessarily the prolonged 
INR or hemostatic modalities; instead, it was severe local 
infection such as a severe periodontitis at extraction 
site.28,29
Meaning of INR value
In general, most of anticoagulation therapy aims at 
INR range 2.5 to 3.5. In a few cases, which need more 
powerful anti-thrombogenic efficacy, the INR value is 
kept around 4.5,7,8 If a patient has the INR value above 5, 
the risk of spontaneous bleeding increases. Spontaneous 
intestinal bleeding may be very dangerous, therefore it is 
recommended to uppermost level of INR value around 4. 
Almost every patient who takes the OAT has INR range 2 to 
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4 and a healthy adult has INR range 0.9 to 1.3.
There were several reports about the relationship between 
INR value and bleeding. In 2001, Blinder et al. reported 
that INR value did not significantly influence the incidence 
of post-operative bleeding, and concluded that there was 
no significant correlation between INR value and post-
operative bleeding if the proper hemostatic measures were 
used.4,27 The INR value must be regarded as one of the 
reference index, and not an absolute predictive index for 
post-operative bleeding tendency.4,10,25,30-33
In conclusion, even if the INR value is in therapeutic 
range (2 - 4), post-operative hemorrhage can not be 
so serious and can be well controlled in a dental minor 
surgery, especially when the local hemostatic methods are 
used appropriately.
Weighing the risks
Bleeding complications can cause troublesome and 
worrisome situations for patients, but in fact, they are 
less dangerous and less risky than thromboembolic 
complications. Although the risk of thromboembolism 
is relatively low, the consequence is serious and can be 
fatal.34 In addition, the possibility of thromboembolic 
complications is not predictable because these 
complications often have sudden onset. Because of 
its sudden onset, the anticoagulation therapy must 
be continued in order to lower the possibility of 
thromboembolism.
In the literature’s view, a few case reports supported the 
discontinuing the anticoagulant therapy, while, a number 
of randomized and/or controlled clinical trial supported 
the continuing the OAT.3-7,14-16,18,19,22,25,27,31-33,35-37 According 
to the recommendation recently published in Evidence-
Based Clinical Practice Guidelines from American college 
of Chest Physicians, in patients who require a minor 
dental procedure, it is suggested to continue the Vitamin 
K antagonist (VKAs) such as warfarin (which is used for 
antithrombogenesis) with co-administration of an oral 
prohemostatic agent or to stop the VKAs only for 2 to 3 
days before the dental procedure when the patient has low 
risk of complications.2
Clinical strategies
There are several strategies about the peri-operative 
OAT control in clinical situation1. First strategy is to 
discontinue the OAT. Routinely, the anticoagulants such 
as warfarin have been recommended to be stopped for 5 
- 7 days before a surgery in dental practice. According to 
the articles which were reviewed, this routine strategy of 
stopping the anticoagulants 5 - 7 days before minor dental 
surgery and re-taking after surgery is not recommended 
any more.1,2,4,5,31 Potential mortality risks associated with 
the intravascular thromboembolism obviously outweigh the 
post-operative bleeding complication after dental surgery 
such as post-operative bleeding, regardless of how severe 
dental condition can be.
Second strategy is decreasing the level of anticoagulation. 
This strategy has been recommended for patients with high 
INR values because of the risk of severe post-operative 
bleeding. However, the correlation between the INR value 
and the incidence of post-operative bleeding is significantly 
low. Pre-operative INR value is not an absolute indicator of 
the post-operative bleeding risk.6,10,25,30-33
Third strategy is 'bridging therapy' which means 
replacing oral anticoagulants with heparin injections.29,36 
The main advantage of this approach is that it reduces 
the unprotected time down to 12 - 24 hours. But there 
are many disadvantages; it requires hospitalization and 
additional procedure before surgery; it is complex and 
expensive. The bridging therapy is recommended for the 
patient who has very high risk of thromboembolism, 
requires post-operative INR monitoring and has risk of 
major post-operative bleeding. To optimally implement this 
strategy, the high level of interdisciplinary cooperation is 
necessary.
The last strategy is continuing the anticoagulant therapy. 
According to our literature review, the current scientific 
evidence did not support the modification of the OAT 
regimen in patients with INR < 3.5.30,35 As mentioned 
earlier, the risks of thromboembolism resulting from 
the discontinuing the anticoagulation or the decreased 
anticoagulation level is greater than the risk of local post-
operative bleeding. The evidence weighs heavily in favor 
of not changing the OAT regimen before minor surgery. In 
some rare cases, bleeding after surgery can occur, but it 
can be well controlled by the oral prohemostatic agent such 
as tranexamic acid mouthwash and/or local hemostatic 
measures such as material (bonewax, surgicel), agent 
(epinephrine solution, ferric sulfate, calcium sulfate), 
suture, pressure dressing, and periodontal pack application.
However, this strategy does not mean that a dentist can 
do any kind of minor surgery without consultation with 
a patient’s physician. The dentist must consult with the 
physician and verify that the patient’s systemic status is 
acceptable for the minor surgical procedure. The purpose 
of the consultation is first, the confirmation of INR value 
within therapeutic range for dental surgical procedures. 
Second, it is to let the physician know that the patient will 
be taken some kind of dental minor surgery. Third, it is to 
schedule the dental surgery appointment 2 - 3 days after 
the patient’s routine INR check appointment if possible.
Viewpoint of endodontic microsurgery 
Bleeding control after a tooth extraction in the patients 
with anticoagulants was well studied and reviewed in 
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numerous articles.8,10-12,14,15,27 In these studies, post-
extraction bleeding cases were generally well-controlled 
using local hemostatic measures. Pre-operative tranexamic 
acid mouthwash was proven effective in several articles, 
and post-operative procedures such as sutures, local 
pressure, and gauze biting were also effective in the post-
extraction bleeding control.3,11,12,28,30
However, there is a difference between endodontic 
microsurgery and tooth extraction. The endodontic surgeries 
include an apicoectomy, a retrograde preparation of root 
canal, a retrograde filling procedure, and an endodontic 
microsurgery, which is performed under an operating 
microscope.17,38-40 These endodontic procedures are very 
delicate and technique sensitive in nature. Especially when 
a dentist tries to identify the cause of failures of prior non-
surgical or surgical endodontic treatment by inspecting 
and examining the resected root surface, intra-operative 
bleeding control is essential to achieve a successful 
result.17,41-43
In the retrograde filling procedure, bleeding control is also 
one of the most critical steps to accomplish a tight seal 
with retrograde filling materials. Mineral Trioxide Aggregate 
(MTA), which is widely used for retrograde filling material 
nowadays, is interrupted to set if a direct contact with 
the serum and/or blood is present.44-46 Another retrograde 
filling material, super-ethoxybenzoic acid (superEBA), was 
no significantly affected by storage in serum for 24 hours, 
but further long-term studies are necessary.46
In spite of the importance of bleeding control in 
endodontic microsurgery, there were almost no studies 
about the difficulty of intra-operative bleeding control in 
the patients who continue the anticoagulant therapy for 
the endodontic procedures. It is just assumed that if a 
patient has been prescribed the anticoagulant, then the 
patient’s bleeding tendency will be increased and it will be 
harder to achieve a clean view and a perfect hemostasis 
during the inspection of the resected root surface and the 
retrograde filling procedure.
Now, it is important to study and investigate about 
effectiveness of the local hemostatic measures in 
endodontic surgery in the patients with anticoagulants. 
There were many old articles which emphasized that the 
bleeding can be controlled well using the local hemostatic 
measures in the numerous cases but none of them was an 
endodontic surgery case. Further study is required about 
intra-operative bleeding control in endodontic surgery 
patient who is taking the oral anticoagulant therapy.
Conclusions
In a minor dental surgery, the anticoagulation therapy 
should not be discontinued in the majority of patients. 
The risk of significant bleeding in patients on the oral 
anticoagulants is low; the risk of thromboembolism may 
increase in patients on the oral anticoagulants if the OAT is 
temporarily discontinued, which can be fatal.
 In patients who are continuing the anticoagulation 
therapy, post-operative bleeding can be well controlled 
with the local hemostatic measures. In the endodontic 
surgery, further research is necessary to find out whether 
intra-operative bleeding control can be achieved well only 
with local hemostatic measures in patients who continue 
the anticoagulation therapy.
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